20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
Latest news on Humatica, our people, projects and events. For further updates, please view our LinkedIn page.
View Insights
Humatica Ltd. was retained to advise Baird Capital on its acquisition of a majority interest in Collingwood Lighting, a leading designer and supplier of residential,…
Read more
Humatica Ltd. was retained to advise the Riverside Company on its investment in Swiss manufacturer TECSEDO RE through Panels S.A., a portfolio holding of The…
Read more
As the PE industry matures and successful deals get trickier to execute, ESG guidance becomes more important. Compliance requirements are logically tightening all around. This…
Read more
At the recent PEI Operating Partners Forum Europe, there was consensus: organisational effectiveness and talent management are the foundation for implementing all value creation levers.…
Read more
Please click on the link to view full Press Release Humatica supports Partners Group and Capvis
Read more
Systems implementation is notorious for high project risk and failure to deliver anticipated benefits. In particular, private equity, with its limited timeline for investment, struggles…
Read more
With EBIT multiples reaching uncomfortable heights, there is no room for error in executing the value creation plan. And, management drives the pace. This month’s…
Read more
Digitalisation is disrupting business. But it is having an even more profound impact on organisations, behaviour and leadership. Rudimentary activities are being made redundant, and AI…
Read more
What got you there, won’t get you there Hyper-competitive deal markets and full-prices are changing the rules of the game. Private equity sponsors and portfolio…
Read more
Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products…
Read more
